In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 74 for your search:
Cancer Type/Condition:  Breast cancer, female
Stage/Subtype:  breast cancer in situ
Trial Status:  Closed
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-979254, NCI-P98-0135

2.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 26 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-98-04, CDR0000067020, CAN-NCIC-MA26, CALGB-49801, RTOG-DEV-1026, MA26, NCT00003857

3.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069015, E-2193, NCI-P01-0194, ECOG-E2193, NCT00026286

4.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069217, NCCTG-N99C7, NCI-P02-0204, NCT00030914

5.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NSABP-B-17, CLB-8793, MAOP-1285, NCOG-NSABP-B-17

6.

Phase: Phase III
Type: Treatment
Status: Completed
Age: pre/postmenopausal
Sponsor: NCI
Protocol IDs: NSABP-B-24

7.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NSABP B-39/RTOG 0413, NSABP-B-39, RTOG-0413, SWOG-NSABP-B-39, NCI-2009-00698, NCT00103181

8.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000530309, NCCTG-N06C4, N06C4, NCT00438659

9.

Phase: Phase III
Type: Prevention, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065314, CALGB-49901, S9630, U10CA037429, U10CA032102, SWOG-S9630, SWOG-9630, NCT00002920

10.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Postmenopausal
Sponsor: NCI, Other
Protocol IDs: NSABP B-35, SWOG-NSABP-B-35, NCCTG-NSABP-B-35, ACOSOG-NSABP-B-35, NCT00053898

11.

Phase: Phase II
Type: Natural history/Epidemiology
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065370, U10CA021115, E-5194, NCT00002934

12.

Phase: Phase II
Type: Prevention
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: ID94-029, P30CA016672, MDA-ID-94029, NCI-P97-0113, CDR0000065829, NCT00003099

13.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 23 to 47
Sponsor: NCI
Protocol IDs: CDR0000066428, NCI-98-C-0123, MB-402, NCT00019500

14.

Phase: Phase II
Type: Prevention, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-99017, NCI-G99-1662, NCT00004247

15.

Phase: Phase II
Type: Supportive care
Status: Completed
Age: Postmenopausal (20 and over)
Sponsor: NCI, Other
Protocol IDs: CDR0000069219, U10CA076001, CALGB-79805, NCI-P02-0206, NCT00031720

16.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: ICC4102, P30CA043703, CWRU-ICC-4102, NCT00054301

17.

Phase: Phase II
Type: Prevention, Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: CNR-IEO-007, U01-CA77188-01

18.

Phase: Phase II
Type: Prevention, Treatment
Status: Completed
Age: Postmenopausal
Sponsor: NCI, Other
Protocol IDs: 040044, 04-C-0044, NCT00073073

19.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000365456, P30CA006927, 03026, FCCC-03026, NCT00084539

20.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 35 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000375585, DFCI-00024, UCLA-0210012-02, NCT00090857

21.

Phase: Phase II
Type: Supportive care
Status: Completed
Age: 45 to 65
Sponsor: NCI, Other
Protocol IDs: CDR0000428460, P30CA016042, UCLA-0410033-01, NCT00112749

22.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Postmenopausal
Sponsor: NCI, Other
Protocol IDs: J0365 CDR0000446285, P30CA006973, JHOC-J0365, JHOC-SKCCC-J0365, JHOC-IRB-03100706, NCT00244959

23.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: JHOC-J0485, CDR0000477214, P50CA088843, P30CA006973, JHOC-J0485, SKCCC-J0485, J0485, JHOC-SKCCC-J0485, JHOC-04100404, NCT00334542

24.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention, Treatment
Status: Completed
Age: Postmenopausal
Sponsor: NCI, Other
Protocol IDs: J05100, CDR0000485361, P30CA006973, JHOC-J05100, JHOC-SKCCC-J05100, J05100, NCT00354640

25.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CDR0000522934, UCSF-047522, UCSF-H8409-26206-01, MSKCC-06041, NCT00416403
1    
New Search